Global Dronabinol (CAS 1972-08-3) Market Research Report 2021

Dronabinol is a form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana). THC demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors, which results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. Due to its evidence as an appetite stimulant and an anti-nauseant, Dronabinol is approved for use in anorexia associated with weight loss in patients with AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
In 2019, the global Dronabinol (CAS 1972-08-3) market is led by North America. Europe is the second-largest region-wise market.
Noramco, Canopy Growth, THC Pharm, Echo Pharmaceuticals and Aphios Corporation are the major players in the world, top five manufactures occupied nearly 52% of the revenue market share in 2019.
In terms of types, Purity 99% occupied the largest sales share of about 72% in 2019.

The global Dronabinol (CAS 1972-08-3) market was valued at US$ 150.3 million in 2019 and is expected to reach US$ 191.9 million by the end of 2026, growing at a CAGR of 4.5% during 2021-2026.
This report focuses on Dronabinol (CAS 1972-08-3) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Dronabinol (CAS 1972-08-3) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Dronabinol (CAS 1972-08-3) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Purity 98%
Purity 99%

Segment by Application
Capsule
Oral Liquid

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Canopy Growth
Noramco
KinetoChem
Entourage Phytolab
THC Pharm
Echo Pharmaceuticals
BOL Pharma
Aphios Corporation
Benuvia Manufacturing

Frequently Asked Questions